Navigation Links
MarketsandMarkets: Global Endoscopy Market worth $9.7 Billion by 2016
Date:5/29/2012

DALLAS, May 29, 2012 /PRNewswire/ --

The "Global Endoscopy Market by Product, Application & Technology (2011- 2016)" analyzes and studies the major market drivers, restraints, and opportunities in Americas, Europe, Asia, Japan and Rest of the World.

Browse market data tables and in-depth TOC of "Global Endoscopy Market by Product, Application & Technology (2011- 2016)".
http://www.marketsandmarkets.com/Market-Reports/endoscopy-devices-market-689.html
Early buyers will receive 10% customization on reports.

This report studies "the Global Endoscopy Market By Application, Product & Technology over the forecast period 2011-2016".

The global healthcare industry has seen a shift in paradigm and is now skewed toward less-invasive therapies that not only cures serious illnesses, but also have fewer serious side effects. Demand for endoscopy has increased manifolds over the past decade owing to patient preference for minimally invasive surgeries.

The global endoscopy market was valued at $6.1 billion in the year 2011 and is expected to be $9.7 billion in the year 2016. North America was the largest endoscopy market, followed by Europe and Japan (2011). In the next five years, Asian countries are slated to register a maximum CAGR of 14.42% owing to increased healthcare spending by the government, healthcare reforms and increased patient awareness about minimally invasive surgeries (MIS).

Global endoscopy market is broadly segmented into the following product categories; rigid endoscopes, flexible endoscopes, endoscopy visualization systems, endoscopic ultrasounds, endoscopy fluid management systems, and endoscope
'/>"/>

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
2. MarketsandMarkets: Healthcare Information Technology Systems Market to be Worth $53.8 Billion by 2014
3. MarketsandMarkets: Patient Monitoring Devices Markets in Brazil, Russia, India and China Worth $2,992 Million by 2015
4. MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015
5. MarketsandMarkets: Global Minimally Invasive Surgery (MIS) Market Worth US$ 90.4 Billion by 2015.
6. MarketsandMarkets: Global Top 10 Drug Discovery Technologies Market to be $54 Billion by 2015
7. MarketsandMarkets: Lung Cancer Surgery Market (Devices & Treatment Outlook) to be US$ 46.5 Billion by 2015
8. MarketsandMarkets: Global Top 10 Medical Devices Market (2010 - 2015)
9. MarketsandMarkets: Global Diagnostic Imaging Market Estimated to Reach $26.6 Billion by 2016
10. MarketsandMarkets: "Radiopharmaceuticals for Therapy and PET/SPECT Imaging" Market to reach $4,734 Million by 2015
11. MarketsandMarkets: Global Fetal and Neonatal Care Equipment Market Forecast (2011-2016)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015  Today we bring you a special edition of #MedicareMonday on Medicare,s ... about some of our Medicare resources and continue highlighting the success of the prescription ... Check out our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)...  Amgen (NASDAQ: AMGN ) today announced ... Key results include: , Total revenues increased ... to $5,370 million, with 6 percent product sales ... Prolia ® (denosumab), Sensipar ® (cinacalcet), ... (denosumab). Unfavorable changes in foreign exchange rates impacted ...
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... poultry ... processing plants., SHREVEPORT, La., Nov. ... poultry processing, was identified,in an October 2007 Watt Poultry USA article ... in large-scale processing plants, University of,Georgia Associate Professor of Poultry Science ...
... American Heart Association Scientific Sessions 2007 ... ... Nov. 6 ARCA Discovery, a privately held,biopharmaceutical company, announced today ... bucindolol, a,next-generation beta-blocker and vasodilator for heart failure, atrial,fibrillation, and arrhythmia, ...
Cached Medicine Technology:FreshFx Recognized for use in the Scalder as a Solution to the 'Yield/Pathogen Reduction Dilemma' 2ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia 2ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia 3ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia 4ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia 5
(Date:7/31/2015)... ... ... M3 USA MDLinx.com, source of the Smartest Doc Board Exam Prep in ... The additions of Gastroenterology, Pulmonology and Allergy/Immunology round out an already robust selection of ... easy and painless. MDLinx offers thousands of board-exam style questions and exam-specific content ...
(Date:7/31/2015)... New York (PRWEB) , ... ... ... trial attorney Jason T. Brown’s live lecture on pharmaceutical negligence is now ... 28th, 2015 was well received with a 94% approval rating from the ...
(Date:7/31/2015)... ... 2015 , ... Creating one of the most modern fertility centers in the ... that goes beyond the boundaries of fertility medicine. , As the leading gynecology ... dependable patient support, affordable treatments, unending hope, and high fertility success rates — all ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... The 2015 ... when Major League Baseball and the Boston Red Sox honor Ice Bucket co-founders Pat ... challenge. MLB is donating $100,000 to further collaborative efforts among the ALS organizations to ...
(Date:7/31/2015)... ... ... The Heart Fit Clinic has increased a patient's fitness level 60 percent without ... versus 100 beats, this is a big deal," says Diamond Fernandes, director of the ... with heart disease," he adds. People with angina are able to do a lot ...
Breaking Medicine News(10 mins):Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 4Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... , ... to become inaugural members. , ... (PRWEB) February 17, 2010 -- The MIT Center for Transportation ... research consortium at its annual Crossroads Conference on March 25, 2010, in Cambridge, ...
... , , ARLINGTON, ... from a tax planning perspective is a niche market vastly underserved ... Alan Gassman and Lester Perling , who will host ... and Group Medical Practices: Tax, Health Law, and Creditor Protection Planning ...
... WINNIPEG , Feb. 17 /PRNewswire/ - Following the ... self-contained unit for filling IV syringes and bags - into ... more sales for installation in 2010, medical device company Intelligent ... systems for cytotoxic drug preparation in 2010. This sale was ...
... , GRAND RAPIDS, Mich. , Feb. ... cause of death in the United States for all ... America,s Phytonutrient Report: Heart Health by Color* , shows ... natural plant-based compounds that give fruits and vegetables their vibrant colors ...
... LEBANON, Tenn. , Feb. 17 Health Connect ... three-year title sponsor for its Spring and Fall Hospital Pharmacy ... because its conferences provide directors of pharmacy access to an ... efficient way to learn more about the various ways Cardinal ...
... 100 centers worldwide indicate that belatacept, a first-in-class costimulation ... The results also suggest that it may provide similar ... side effects and superior kidney function after 12 months. ... Journal of Transplantation , provides the first findings to ...
Cached Medicine News:Health News:MIT's Center for Transportation & Logistics Announces new Environmental Performance Consortium at Annual Crossroads Conference 2Health News:MIT's Center for Transportation & Logistics Announces new Environmental Performance Consortium at Annual Crossroads Conference 3Health News:MIT's Center for Transportation & Logistics Announces new Environmental Performance Consortium at Annual Crossroads Conference 4Health News:The Doctor Is in...But Where Is the Tax Advisor? 2Health News:The Doctor Is in...But Where Is the Tax Advisor? 3Health News:The Doctor Is in...But Where Is the Tax Advisor? 4Health News:World's Leading Manufacturer of IV Solutions Chooses Three RIVA Systems 2Health News:Americans Falling Short on Heart-Healthy Fruits and Vegetables 2Health News:Americans Falling Short on Heart-Healthy Fruits and Vegetables 3Health News:Americans Falling Short on Heart-Healthy Fruits and Vegetables 4Health News:Health Connect Partners Welcomes Cardinal Health as Three-Year Title Sponsor 2Health News:New drug for kidney transplant recipients effective in humans 2
... Biotrace Sterile Barium Sulfate USP is ... and consistent imaging capabilities for todays ... via minimally invasive surgery. Comprised of ... an even diffusion of sterile barium, ...
... Cement consists of a two ... bone cement liquid within a ... polyethylene bag,containing bone cement powder ... interiors of the blister pack,and ...
... Bone Cement consists of a ... containing bone cement liquid within ... sterile polyethylene bag,containing bone cement ... The interiors of the blister ...
... Radiopaque Bone Cement consists of ... sterile,ampule containing bone cement liquid ... a sterile polyethylene bag,containing bone ... pouch. The interiors of the ...
Medicine Products: